Combined modality treatments in early non-small cell lung cancer

Saved in:
Bibliographic Details
Published inLung cancer (Amsterdam, Netherlands) Vol. 38; no. 1; pp. S23 - S25
Main Authors Harper, Peter, Marx, Gavin M
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.10.2002
Subjects
Adult
Age Factors
Aged
Antibodies, Monoclonal - therapeutic use
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - radiotherapy
Carcinoma, Non-Small-Cell Lung - surgery
Chemotherapy, Adjuvant
Combined Modality Therapy
Combined modality treatment
Drug Costs
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - pathology
Lung Neoplasms - radiotherapy
Lung Neoplasms - surgery
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Non-small cell lung cancer
Prognosis
Treatment outcomes
Treatment outcomes
Combined modality treatment
Non-small cell lung cancer
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(02)00248-9